Lauren Lewis Becomes Managing Director and Nicholas Megjugorac, PhD Moves to Head of Strategy New York (February 4, 2016) — McCann Health North America today announced that Mark Willmann, currently Executive […]
– Takeda obtains rights to Mersana’s XMT-1522 outside U.S. and Canada – – Takeda to create additional Fleximer ADCs; Mersana to have a co-development option – – Mersana to receive […]
LAM Therapeutics Closes $40M in Financing and Announces Two Clinical-Stage Programs in Rare Diseases and Cancer Bringing the Total Raised for the Current Class of 4Catalyzer Companies to a Quarter-Billion […]
PulseCX announced today that Ed Nathan has joined the company as Executive Vice President, Chief Creative Officer.
January 29, 2016 Dayton, N.J. – Aurobindo Pharma Limited has received final approval from the U.S. Food and Drug Administration for Voriconazole Tablets, 50 mg and 200 mg. The […]
FOSTER CITY, Calif.–(BUSINESS WIRE)–Gilead Sciences, Inc. (Nasdaq:GILD) today announced that, effective March 10, 2016, current Chairman and CEO John C. Martin, PhD will assume the role of Executive Chairman of […]
HYDERABAD, India & PRINCETON, N.J.–(BUSINESS WIRE)–Dr. Reddy’s Laboratories (BSE: 500124, NSE: DRREDDY, NYSE: RDY) announced today that the U.S. Food and Drug Administration (FDA) has approved ZEMBRACE™SymTouch™ (sumatriptan succinate) injection, […]
The pharma sector has been thrust into finding alternatives that will enable it to maintain an edge in the face of advancing technology, shifting priorities and evolving expectations.
Former GA Communications Group changes name, teams up to expand operations After more than 30 years in the pharmaceutical and healthcare advertising arena, GA Communications Group has a new […]
Company to focus on pipeline of Pentarins™ as a unique and promising approach to treating solid tumor cancers Lead drug candidate PEN-221 targeting neuroendocrine and small cell lung cancers to […]
